Invention Grant
- Patent Title: RNA agents for P21 gene modulation
-
Application No.: US14979568Application Date: 2015-12-28
-
Publication No.: US10405749B2Publication Date: 2019-09-10
- Inventor: Kenjirou Minomi , Jens Harborth , Cima Cina , Kwok Yin Tsang , Wenbin Ying , Hirokazu Takahashi
- Applicant: Nitto Denko Corporation
- Applicant Address: JP Osaka
- Assignee: Nitto Denko Corporation
- Current Assignee: Nitto Denko Corporation
- Current Assignee Address: JP Osaka
- Agency: Knobbe, Martens, Olson & Bear, LLP
- Priority: JP2014-266198 20141226
- Main IPC: C12N15/113
- IPC: C12N15/113 ; C07H21/02 ; C07H21/04 ; C07F9/6533 ; C12Q1/02 ; G01N33/58 ; A61B5/00 ; A61K49/00 ; C07D311/30 ; A61K31/713

Abstract:
This invention provides compounds, compositions and methods for modulating the expression of human p21 using RNA interference. The RNA interference molecules can be used in methods for preventing or treating diseases such as malignant tumor. A nucleic acid molecule can have a) a polynucleotide sense strand and a polynucleotide antisense strand; b) each strand of the molecule being from 15 to 30 nucleotides in length; c) a contiguous region of from 15 to 30 nucleotides of the antisense strand being complementary to a sequence of an mRNA encoding p21; and d) at least a portion of the sense strand can be complementary to at least a portion of the antisense strand, and the molecule has a duplex region of from 15 to 30 nucleotides in length.
Public/Granted literature
- US20160208255A1 RNA AGENTS FOR P21 GENE MODULATION Public/Granted day:2016-07-21
Information query
IPC分类: